Parallax Volatility Advisers’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $33M | Sell |
1,207,200
-807,300
| -40% | -$21.5M | 0.09% | 169 |
|
|
2025
Q4 | $50.2M | Buy |
2,014,500
+987,200
| +96% | +$24.9M | 0.1% | 157 |
|
|
2025
Q3 | $26.2M | Buy |
1,027,300
+614,600
| +149% | +$15.2M | 0.04% | 244 |
|
|
2025
Q2 | $10M | Sell |
412,700
-184,400
| -31% | -$4.3M | 0.02% | 429 |
|
|
2025
Q1 | $15.1M | Sell |
597,100
-42,800
| -7% | -$1.12M | 0.04% | 338 |
|
|
2024
Q4 | $17M | Buy |
639,900
+53,000
| +9% | +$1.44M | 0.03% | 392 |
|
|
2024
Q3 | $17M | Sell |
586,900
-211,900
| -27% | -$6.18M | 0.03% | 374 |
|
|
2024
Q2 | $22.4M | Buy |
798,800
+291,700
| +58% | +$8.03M | 0.05% | 278 |
|
|
2024
Q1 | $14.1M | Sell |
507,100
-848,000
| -63% | -$23.5M | 0.03% | 406 |
|
|
2023
Q4 | $39M | Buy |
1,355,100
+419,800
| +45% | +$12.7M | 0.08% | 233 |
|
|
2023
Q3 | $31M | Sell |
935,300
-635,500
| -40% | -$22.5M | 0.07% | 224 |
|
|
2023
Q2 | $57.6M | Buy |
1,570,800
+821,400
| +110% | +$32M | 0.13% | 139 |
|
|
2023
Q1 | $30.6M | Sell |
749,400
-1,909,800
| -72% | -$82.5M | 0.06% | 292 |
|
|
2022
Q4 | $136M | Buy |
2,659,200
+1,291,700
| +94% | +$61.9M | 0.21% | 85 |
|
|
2022
Q3 | $59.8M | Sell |
1,367,500
-1,029,600
| -43% | -$50M | 0.09% | 237 |
|
|
2022
Q2 | $126M | Buy |
2,397,100
+1,019,300
| +74% | +$51.9M | 0.12% | 116 |
|
|
2022
Q1 | $71.3M | Sell |
1,377,800
-1,524,700
| -53% | -$79.1M | 0.04% | 198 |
|
|
2021
Q4 | $171M | Buy |
2,902,500
+243,000
| +9% | +$12M | 0.2% | 62 |
|
|
2021
Q3 | $114M | Buy |
2,659,500
+533,300
| +25% | +$23.6M | 0.11% | 137 |
|
|
2021
Q2 | $83.3M | Buy |
2,126,200
+7,800
| +0.4% | +$303K | 0.11% | 126 |
|
|
2021
Q1 | $76.7M | Sell |
2,118,400
-2,089,300
| -50% | -$74.2M | 0.17% | 93 |
|
|
2020
Q4 | $155M | Sell |
4,207,700
-459,307
| -10% | -$16.8M | 0.16% | 100 |
|
|
2020
Q3 | $163M | Buy |
4,667,007
+1,870,640
| +67% | +$65.6M | 0.12% | 137 |
|
|
2020
Q2 | $86.8M | Buy |
2,796,367
+978,849
| +54% | +$33.3M | 0.1% | 156 |
|
|
2020
Q1 | $56.3M | Sell |
1,817,518
-133,436
| -7% | -$4.55M | 0.07% | 187 |
|
|
2019
Q4 | $72.5M | Sell |
1,950,954
-130,064
| -6% | -$4.63M | 0.08% | 172 |
|
|
2019
Q3 | $70.9M | Buy |
2,081,018
+423,603
| +26% | +$15.4M | 0.08% | 139 |
|
|
2019
Q2 | $68.1M | Sell |
1,657,415
-191,301
| -10% | -$7.6M | 0.07% | 140 |
|
|
2019
Q1 | $74.5M | Buy |
1,848,716
+1,130,310
| +157% | +$45.3M | 0.08% | 109 |
|
|
2018
Q4 | $29.8M | Buy |
718,406
+151,038
| +27% | +$6.27M | 0.04% | 272 |
|
|
2018
Q3 | $23.7M | Buy |
567,368
+189,931
| +50% | +$7.31M | 0.03% | 251 |
|
|
2018
Q2 | $13M | Buy |
377,437
+245,265
| +186% | +$8.38M | 0.02% | 370 |
|
|
2018
Q1 | $4.45M | Sell |
132,172
-485,156
| -79% | -$16.7M | 0.01% | 553 |
|
|
2017
Q4 | $21.2M | Sell |
617,328
-682,570
| -53% | -$23.3M | 0.03% | 247 |
|
|
2017
Q3 | $44M | Buy |
1,299,898
+655,588
| +102% | +$21.1M | 0.07% | 145 |
|
|
2017
Q2 | $20.5M | Sell |
644,310
-250,958
| -28% | -$7.91M | 0.04% | 252 |
|
|
2017
Q1 | $29.1M | Sell |
895,268
-854,899
| -49% | -$27M | 0.06% | 187 |
|
|
2016
Q4 | $53.9M | Buy |
1,750,167
+272,564
| +18% | +$8.32M | 0.11% | 137 |
|
|
2016
Q3 | $47.5M | Sell |
1,477,603
-498,752
| -25% | -$16.7M | 0.09% | 142 |
|
|
2016
Q2 | $66M | Sell |
1,976,355
-18,019,711
| -90% | -$575M | 0.13% | 99 |
|
|
2016
Q1 | $562M | Buy |
19,996,066
+19,644,241
| +5,584% | +$561M | 1.23% | 7 |
|
|
2015
Q4 | $10.8M | Sell |
351,825
-364,473
| -51% | -$11.5M | 0.02% | 437 |
|
|
2015
Q3 | $21.3M | Sell |
716,298
-1,554,756
| -68% | -$49.9M | 0.05% | 256 |
|
|
2015
Q2 | $72.2M | Sell |
2,271,054
-1,126,515
| -33% | -$36.7M | 0.15% | 86 |
|
|
2015
Q1 | $112M | Buy |
3,397,569
+1,787,795
| +111% | +$56.8M | 0.27% | 52 |
|
|
2014
Q4 | $47.6M | Buy |
1,609,774
+1,285,564
| +397% | +$36.9M | 0.14% | 147 |
|
|
2014
Q3 | $9.1M | Sell |
324,210
-841,830
| -72% | -$23.6M | 0.03% | 489 |
|
|
2014
Q2 | $32.8M | Buy |
1,166,040
+1,165,724
| +368,900% | +$33.2M | 0.14% | 112 |
|
|
2014
Q1 | $10K | Sell |
316
-118,470
| -100% | -$3.53M | ﹤0.01% | 3050 |
|
|
2013
Q4 | $3.45M | Sell |
118,786
-812,107
| -87% | -$23.6M | 0.02% | 524 |
|
|
2013
Q3 | $25.4M | Sell |
930,893
-411,165
| -31% | -$11.2M | 0.13% | 139 |
|
|
2013
Q2 | $35.7M | Buy |
+1,342,058
| New | +$37.1M | 0.17% | 107 |
|
Other funds holding PFE
VCM
VPM
Parallax Volatility Advisers's PFE Position: Q1 2026 in Review
Parallax Volatility Advisers opened a new position in Pfizer (PFE) in Q1 2026: 7 shares worth $197. The stake represents ﹤0.01% of the portfolio and ranks #1401 among its holdings. This is a return to the name: Parallax Volatility Advisers previously reported a position in PFE as recently as Q2 2025.
Parallax Volatility Advisers first reported a position in PFE in Q2 2013 and has held it in 35 quarters since. The position peaked at $46.9M in Q3 2021. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Parallax Volatility Advisers held 7 shares of Pfizer worth $197 as of Q1 2026.
- Pfizer was a new Parallax Volatility Advisers position in Q1 2026.
- Pfizer made up ﹤0.01% of Parallax Volatility Advisers's portfolio in Q1 2026, its #1401 holding.
- Parallax Volatility Advisers first reported a position in Pfizer in Q2 2013 and has held it in 35 quarters since.
- Parallax Volatility Advisers's Pfizer position peaked at $46.9M in Q3 2021.
- 2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Parallax Volatility Advisers's 13F filing for Q1 2026, filed 15 May 2026.